Contact Us



Docquity has become the latest addition to Zuellig Pharma's growing digital investment portfolio. The Singapore-based HealthTech startup aims to connect medical professionals globally over a secure digital platform. Its current reach spans 7 markets in Asia with more than 60,000 users and over 1,000 specialized groups.

Through Docquity, doctors are now able to discuss cases through a secure peer-to-peer learning network. Engagement on the platform varies from discussing clinical cases to browsing journals, and includes a reward system that allocates points for contributions. Doctors on the platform can also accrue *CME (Continuing Medical Education) points by participating in educational activities.

This is the first online learning community dedicated to doctors in the region. It functions like a social network and is an invite-only platform that validates users before giving them access. The company is supported by numerous medical associations across the region, who have invited their membership of doctors to join the community.

All materials shared on the platform are indexed, so every time a doctor needs critical information or second opinions, they have instant access to medical peers around the world. The platform also allows doctors to build their reputation by sharing their experience and knowledge with younger doctors who are eager to interact and learn.

"We believe the platform can help our clients in the pharmaceutical industry engage with doctors in meaningful ways. Beyond that, we see the positive impact that Docquity can make on healthcare outcomes and we are keen to accelerate this," said SVP Corporate Development Maarten Kelder.

In 2017, Zuellig Pharma made its first HealthTech investment in Klinify, a digital medical assistant that helps doctors manage their patients seamlessly. "We see the immense value that passionate and driven entrepreneurs can bring to the table. Both Klinify and Docquity are great examples of this. We are constantly impressed by their commitment to improve access to high quality healthcare, which is very much in line with our purpose," Maarten said.

CEO and Co-Founder of Docquity, Indranil Roychowdhury, comments "Our network is growing and generating trusted clinical knowledge every single day, and the engine is learning from this to help doctors make better informed, data-driven decisions. We are extremely excited to partner with Zuellig Pharma, as we see a potent mix of domain expertise, market understanding and technology coming together to help doctors through continual learning."

*all doctors are required to obtain a minimum number of points to renew their practising certificate.”